Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
AMPRONIX
SCHILLER AG

Magnetic Field Correlation MRI Reveals Low Brain Iron in ADHD Patients

By Medimaging International staff writers
Posted on 17 Dec 2013
Image: Medication-naïve ADHD patients (ADHD-nonmedicated) have reduced striatal (putamen (PUT), caudate nucleus (CN)) and thalamic (THL) magnetic field correlation (MFC) measures of brain iron compared to controls and psychostimulant medicated ADHD patients (ADHD-medicated); Brain iron measures in PUT, CN, THL or globus pallidus (GP) did not differ between controls and psychostimulant medicated ADHD patients. These statistical significant differences are visible in the MFC group maps (top row) but not in conventional relaxation rate maps: R2 (second row), R2*(third row), and R2\' (bottom row) (Photo courtesy of RSNA).
Image: Medication-naïve ADHD patients (ADHD-nonmedicated) have reduced striatal (putamen (PUT), caudate nucleus (CN)) and thalamic (THL) magnetic field correlation (MFC) measures of brain iron compared to controls and psychostimulant medicated ADHD patients (ADHD-medicated); Brain iron measures in PUT, CN, THL or globus pallidus (GP) did not differ between controls and psychostimulant medicated ADHD patients. These statistical significant differences are visible in the MFC group maps (top row) but not in conventional relaxation rate maps: R2 (second row), R2*(third row), and R2\' (bottom row) (Photo courtesy of RSNA).
Image: Photograph of a Siemens Healthcare (Erlangen, Germany) Magnetom Trio MRI scanner (Photo courtesy of RSNA).
Image: Photograph of a Siemens Healthcare (Erlangen, Germany) Magnetom Trio MRI scanner (Photo courtesy of RSNA).
A new magnetic resonance imaging (MRI) technique offers a noninvasive way to measure iron levels in the brains of individuals with attention deficit hyperactivity disorder (ADHD).

The new findings were presented December 2013 at the annual meeting of the Radiological Society of North America (RSNA), held in Chicago (IL, USA). Researchers reported that the imaging technology could help physicians and parents make better informed decisions about medication.

ADHD is a common disorder in children and adolescents that can continue into adulthood. Symptoms include hyperactivity and difficulty staying focused, paying attention, and controlling behavior. The American Psychiatric Association reports that ADHD affects 3%–7% of school-age children.

Psychostimulant drugs such as Ritalin are among the drugs typical used to decrease ADHD symptoms. Psychostimulants affect levels of dopamine, a neurotransmitter in the brain associated with addiction. “Studies show that psychostimulant drugs increase dopamine levels and help the kids that we suspect have lower dopamine levels,” said Vitria Adisetiyo, PhD, postdoctoral research fellow at the Medical University of South Carolina (Charleston, SC, USA). “As brain iron is required for dopamine synthesis, assessment of iron levels with MRI may provide a noninvasive, indirect measure of dopamine.”

Dr. Adisetiyo and colleagues explored this possibility by measuring brain iron in 22 children and adolescents with ADHD and 27 healthy control children and adolescents employing an MRI technique called magnetic field correlation (MFC) imaging. The technique is comparatively new, having been introduced in 2006 by study coauthors and faculty members Joseph A. Helpern, PhD, and Jens H. Jensen, PhD. “MRI relaxation rates are the more conventional way to measure brain iron, but they are not very specific,” Dr. Adisetiyo said. “We added MFC because it offers more refined specificity.”

The findings demonstrated that the 12 ADHD patients who had never been on medication had substantially lower MFC than the 10 ADHD patients who had been on psychostimulant drugs or the 27 typically developing children and adolescents in the control group. In contrast, no significant group differences were detected using relaxation rates or serum measures. The lower brain iron levels in the nonmedicated group appeared to normalize with psychostimulant medication.

MFC imaging’s ability to identify noninvasively the low iron levels may help improve ADHD diagnosis and guide optimal treatment. Noninvasive techniques are especially important in a pediatric population, Dr. Adisetiyo noted. “This method enables us to exploit inherent biomarkers in the body and indirectly measure dopamine levels without needing any contrast agent,” she said.

If the findings can be repeated in larger studies, then MFC might have a future role in determining which patients would benefit from psychostimulants—an important consideration because the drugs can become addictive in some patients and lead to abuse of other psychostimulant drugs such as cocaine. “It would be beneficial when the psychiatrist is less confident of a diagnosis if you could put a patient in a scanner for 15 minutes and confirm that brain iron is low,” she concluded. “And we could possibly identify kids with normal iron levels who could potentially become addicts.”

Combined with replicating the findings in a larger population of patients, the researchers plan to expand their studies to look at the relationship between cocaine addiction and brain iron.

Related Links:

Medical University of South Carolina



RTI ELECTRONICS AB
RADCAL
SuperSonic Imagine

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.